Evox Therapeutics (NASDAQ:EVOXW) Shares Up 20.4% – Here’s What Happened

Evox Therapeutics plc (NASDAQ:EVOXW) was up 20.4% during mid-day trading on Thursday . The stock traded as high as $0.4221 and last traded at $0.4070. Approximately 206 shares changed hands during trading, a decline of 99% from the average daily volume of 39,797 shares. The stock had previously closed at $0.3380.

Evox Therapeutics Price Performance

The company’s 50 day moving average is $0.37.

Evox Therapeutics plc is a biotechnology company developing therapeutics built on engineered extracellular vesicles (EVs), commonly referred to as exosomes, designed to deliver a broad range of therapeutic payloads. The company’s platform focuses on using naturally occurring nanoscale vesicles as vehicles to carry biologics—such as RNA, proteins and other macromolecules—into target cells and tissues. Evox aims to leverage the innate properties of EVs for targeted delivery, biodistribution and reduced immunogenicity compared with some synthetic delivery systems.

The company’s research and development activities center on engineering EVs for tissue-specific targeting and intracellular delivery, with the goal of addressing diseases that are difficult to treat with conventional approaches, including disorders of the central nervous system and certain rare genetic conditions.